Trials / Completed
CompletedNCT07325422
Weizmannia Coagulans BC99 Relieves Exercise-induced Fatigue
Weizmannia Coagulans BC99 Relieves Exercise-induced Fatigue: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the clinical effects of Weizmannia coagulans BC99 supplementation compared with placebo on plasma amino acid profiles in male university students following a 12-week intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | The experimental phase of this study lasts 12 weeks and each subject will have 3 visits (Week 0, Week 6, Week 12) |
| DIETARY_SUPPLEMENT | BC99 | The experimental phase of this study lasts 12 weeks and each subject will have 3 visits (Week 0, Week 6, Week 12) |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-03-12
- Completion
- 2024-03-30
- First posted
- 2026-01-08
- Last updated
- 2026-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07325422. Inclusion in this directory is not an endorsement.